Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-05-2010 | Editorial

The new FDG brain revolution: the neurovascular unit and the default network

Authors: Stelvio Sestini, Antonio Castagnoli, Luigi Mansi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2010

Excerpt

“Our aim is, more than see new things, to see with new eyes what has already been seen”Baruch Spinoza …

Wagner HN Jr, Knight N. A personal history of nuclear medicine. Springer Verlag; 2006.

Sokoloff L. [1-14C]-2-deoxy-d-glucose-method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the “lumped” constants. Neurosci Res Program Bull 1976;14:466–8.PubMed

Reivich M, Kuhl D, Wolf A, Grenberg J, Phelps M, Ido T, et al. The [F-18]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127–37.PubMed

Reivich M, Alavi A, Greenberg J, Wolf A. [F-18]fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results. Prog Nucl Med 1981;7:138–48.PubMed

Grenberg J, Reivich M, Alavi A, Hand P, Rosenquist A, Rintelmann W, et al. Metabolic mapping of functional activity in human subjects with the [F-18]fluorodeoxyglucose technique. Science 1981;212:678–80.CrossRef

Phelps ME, Mazziotta JC, Huang SC. Study of cerebral function with positron computed tomography. J Cereb Blood Flow Metab 1982;2:113–62.PubMed

Di Chiro G, De La Paz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, et al. Glucose utilization of cerebral gliomas measured by [F-18]fluorodeoxyglucose and positron emission tomography. Neurology. 1982;32:1323–9.PubMed

Engel J Jr, Kuhl DE, Phelps ME. Pattern of human local cerebral glucose metabolism during epileptic seizures. Science 1982;218:64–6.CrossRefPubMed

Theodore WH, Newmark ME, Sato S, Brooks R, Patronas N, De La Paz R, et al. [18F]fluorodeoxyglucose positron emission tomography in refractory complex partial seizures. Ann Neurol 1983;14(4):429–37.CrossRefPubMed

10.

Patronas NJ, Di Chiro G, Smith BH, De La Paz R, Brooks RA, Milam HL, et al. Depressed cerebellar glucose metabolism in supratentorial brain tumors. Brain Res 1984;291:93–101.CrossRefPubMed

11.

von Monakov C. Lokalisation im Gehirn und funktionelle störungen induziert durch kortikale läsionen. Wiesbaden: JF Bergmann; 1914.

12.

Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G. Alzheimer’s disease: focal cortical changes shown by positron emission tomography. Neurology 1983;33:961–5.PubMed

13.

Chase TN, Foster NL, Mansi L. Alzheimer’s disease and the parietal lobe. Lancet 1983;2:225.CrossRefPubMed

14.

Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [F-18]fluorodeoxyglucose. J Comput Assist Tomogr 1983;7:590–8.CrossRefPubMed

15.

Silverman DHS. Evaluating pathology in the brain with nuclear medicine. Semin Nucl Med 2008;38(4):225–6.CrossRefPubMed

16.

Herholz K, Herscovitch P, Heiss WD. Imaging brain function. In: Herholz K, Herscovitch P, Heiss WD, editors. NeuroPET: positron emission tomography in neuroscience and clinical neurology, vol 3. New York: Springer-Verlag; 2004. p. 143–85.

17.

Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897–916.CrossRefPubMed

18.

Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res 1999;24:321–9.CrossRefPubMed

19.

Pellerin L, Magistretti PJ. Let there be (NADH) light. Science 2004;305:50–2.CrossRefPubMed

20.

Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001;21:1133–45.CrossRefPubMed

21.

Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 1994;91:10625–9.CrossRefPubMed

22.

Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci U S A 1998;95:316–21.CrossRefPubMed

23.

Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW. Neural activity triggers neuronal oxidative metabolism followed by astrocytes glycolysis. Science 2004;305:99–103.CrossRefPubMed

24.

Koehler RC, Roman RJ, Harder DR. Astrocytes and the regulation of cerebral blood flow. Trends Neurosci 2009;32(3):160–9.CrossRefPubMed

25.

Sokoloff L, Mangold R, Weschsler RL, Kennedy C, Kety SS. The effect on mental arithmetic on cerebral circulation and metabolism. J Clin Invest 1955;34:1101–8.CrossRefPubMed

26.

Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network. Anatomy, function and relevance to disease. Ann N Y Acad Sci 2008;1124:1–38.CrossRefPubMed

27.

Garrity AG, Pearson GD, McKierman K, Lloyd D, Kiehl K, Calhoun V. Aberrant “default mode” functional connectivity in schizophrenia. Am J Psychiatry 2007;164(3):450–8.CrossRefPubMed

28.

Shulman RG, Rothman DL, Behar KL, Hyder F. Energetic basis of brain activity: implications for neuroimaging. Trends Neurosci 2004;27:489–95.CrossRefPubMed

29.

Barros LF, Porras OH, Bittner CX. Why glucose transport in the brain matters for PET. Trends Neurosci 2005;28:117–9.CrossRefPubMed

30.

Attwell D, Iadecola C. The neural basis of functional brain imaging signals. Trends Neurosci 2002;25:621–5.CrossRefPubMed

31.

Schon EA, Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 2003;111:303–12.PubMed

32.

Mattson PM, Magnus T. Ageing and neuronal vulnerability. Nature 2006;7:278–94.

33.

Fukui H, Morales CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 2008;31(5):251–6.CrossRefPubMed

34.

Sestini S. The neural basis of functional neuroimaging signal with positron and single-photon emission tomography. Cell Mol Life Sci 2007;64:1778–84.CrossRefPubMed

35.

Weng X, Ding YS, Wolkow ND. Imaging the functioning human brain. Proc Natl Acad Sci U S A 1999;96:11073–4.CrossRefPubMed

36.

Silverman DHS, Mosconi L, Ercoli L, Chen W, Small GW. Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Semin Nucl Med 2008;38(4):251–61.CrossRefPubMed

37.

Yu AS, Lin HD, Huang SC, Phelps ME, Wu HM. Quantification of cerebral glucose metabolic rate in mice using 18F-FDG and small-animal PET. J Nucl Med 2009;50:966–73.CrossRefPubMed

38.

Lammerstma AA, Brooks DJ, Beaney RP, Turton DR, Kensett MJ, Heather JD, et al. In vivo measurement of regional cerebral haematocrit using positron emission tomography. J Cereb Blood Flow Metab 1984;4:317–22.

39.

Okazawa H, Yonekura Y, Fujibayashi Y, Yamauchi H, Ishizu K, Nishizawa S, et al. Measurement of regional cerebral plasma pool and haematocrit with Copper-62 labeled HSA-DTS. J Nucl Med 1996;37:1080–5.PubMed

40.

Brooks DJ, Beaney RP, Lammerstma AA, Leenders KL, Horlock PL, Kensett MJ, et al. Quantitative measurement of blood brain barrier permeability using rubidium-82 and positron emission tomography. J Cereb Blood Flow Metab 1984;4:535–45.PubMed

41.

Iannotti F, Fieschi C, Alfano B, Picozzi P, Mansi L, Pozzilli C, et al. Simplified non invasive PET measurement of blood brain barrier permeability. J Comput Assist Tomogr 1987;11:390–7.CrossRefPubMed

42.

Sokoloff L. The physiological and biochemical basis of functional brain imaging. Cogn Neurodyn 2008;2:1–5.CrossRefPubMed

Title: The new FDG brain revolution: the neurovascular unit and the default network
Authors: Stelvio Sestini
Antonio Castagnoli
Luigi Mansi
Publication date: 01-05-2010
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2010
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-009-1327-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The new FDG brain revolution: the neurovascular unit and the default network

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2010

Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer

Extrastriatal uptake on 123I-ioflupane brain SPECT

Clearance of the high intestinal 18F-FDG uptake associated with metformin after stopping the drug

Approaches to quantify radioligands that wash out slowly from target organs

Efficacy of using a standard activity of 131I-MIBG therapy in patients with disseminated neuroendocrine tumours

Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience